Demographic, Survivorship, and Health Characteristics
Demographic, treatment exposures, and chronic health conditions among survivors with short and typical sleep duration are summarized in Table 3. Survivors were 51.8% female, predominately non-Hispanic white (84.1%), an average of 34 years of age, and 26 years from their cancer diagnosis. Leukemia (41.4%), non-central nervous system solid tumors (23.4%), and Hodgkin lymphoma (13.2%) were the most common diagnoses among participants. Grade 2 or higher cardiac (40.8%), endocrine (50.0%), neurologic (31.0%), gastrointestinal/hepatic (31.1 %), musculoskeletal (30.1%) and pulmonary (26.3%) conditions were prevalent in the sample. Grade 2 or higher renal conditions (9.9%), anxiety (6.7%) and depression (7.6%) were less common among survivors. Several health outcomes were more prevalent among short sleepers (< 7 hours) compared to those with typical sleep duration (7 to 9 hours) such as: anxiety 10.6% vs. 3.4% (p<0.0001), depression 10.3% vs. 5.2% (p=0.0100), endocrine 55.8% vs. 45.5% (p=0.0022), pulmonary 30.3% vs. 23.0% (p=0.0147), and gastrointestinal/hepatic conditions 37.0% vs. 26.3% (p=0.0006) (Table 3).